Cancer BiologyCell Death and DifferentiationPeer-reviewed
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers
Vida Kufrin, Annika Seiler, Silke Brilloff…·Alexander Arthur Wurm
This study identifies KAT2A as a therapeutic target in a subset of well-differentiated, microsatellite-stable colorectal cancers by showing its dependency and functional consequences.
14 citationstop 1%